Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 374.05 5.15  | 1.40% -45.97% 13.16 10,540.39
NSE Price: Sep 16, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 16, 15:59 374.05 5.15 1.40% 366.00 368.90 1,683,232 363.20 - 381.95
BSE Sep 16, 2019 373.55 4.70 1.27% 368.85 368.85 122,652 364.80 - 381.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,031,470 P/B: 1.85 NSE Code: GLENMARK
52-Week Range: R 353.50 - 705.90 Dividend Yield: 0.54% BSE Code: 532296
TTM EPS: R 28.40 Book Value: R 202.14 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -46.77 -11.24 -29.49 -45.13 -24.99 -13.68 5.30
S&P BSE Mid Cap -11.48 2.27 -8.12 -15.06 1.80 6.47 8.71
S&P BSE Healthcare -6.47 3.54 0.11 -18.26 -7.19 -1.15 12.71
Company's return has been calculated on basis of NSE's price.
As on Sep 13, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.72 9.27 10.66
Net Profit 15.07 7.57 11.14
EPS 15.08 7.56 10.39
Book Value 8.57 15.53 12.51
Average
Operating Margin 18.18 19.95 19.48
Net Margin 9.18 10.04 8.61
Return on Networth 17.21 20.40 19.49
Return on Investment 16.47 17.26 16.54
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -9.39 7.26 -9.39
Operating Profit -14.78 -29.17 -14.78
Net Profit -32.40 -53.10 -32.40
EPS -32.41 -53.11 -32.41
TTM
Revenue 1.59 12.54 1.59
Operating Profit -7.89 3.33 -7.89
Net Profit -13.37 13.90 -13.37
EPS -13.38 13.91 -13.38
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 10,540.39 10,022.73 801.28 7.94 17.21 1.85 13.16
Lupin 34,812.01 17,280.63 711.14 4.01 4.55 2.52 49.25
Torrent Pharmaceuticals 28,927.92 7,823.00 489.00 6.21 9.34 5.86 59.16
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 20, 2019 ROBIN PINTO  Buy Market 2,000 374.20 7.48
Jun 28, 2019 CHERYLANN PINTO  Buy Market 1,000 443.35 4.43
Jun 27, 2019 CHERYLANN PINTO  Buy Market 3,300 448.20 14.79
Jun 27, 2019 GLENN SALDANHA  Buy Market 11,080 448.20 49.66
Jun 25, 2019 BLANCHE SALDANHA  Buy Market 13,100 455.55 59.68
Fund Houses invested in the stock
Fund Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
HDFC Mutual Fund 2.990 2.894 2.789 2.702 2.673
DSP Mutual Fund 0.761 0.578 0.444 0.330 0.475
Kotak Mahindra Mutual Fund 0.601 0.270 0.127 0.395 0.336
IDFC Mutual Fund 0.189 0.005 0.001 0.018 0.007
SBI Mutual Fund 0.098 0.293 0.328 0.258 -
Axis Mutual Fund 0.096 0.012 0.008 - 0.017
UTI Mutual Fund 0.089 0.035 0.032 0.056 -
ICICI Prudential Mutual Fund 0.070 0.007 0.002 0.006 0.004
BOI AXA Mutual Fund 0.037 0.001 0.001 - -
Invesco Mutual Fund 0.032 - - - 0.001
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
2.76
Piotroski F-Score
7
Modified C-Score
1
5-Years Price to Earnings
12.99
5-Years Price to Book
1.82
Earnings Yield
EBIT / Enterprise value
10.65%
PEG
Price / Earnings to growth ratio
2.18
Related Stocks
  Current Price   Chng %
Abbott India R9,828.65 -0.05%
Alkem Laboratories R1,859.80 +1.10%
Biocon R230.85 -0.77%
Cadila Healthcare R242.30 +0.17%
Glaxosmithkline Pharma R1,385.25 +1.65%
Lupin R769.15 +0.66%
Pfizer R3,321.20 +1.03%
Sanofi India R5,884.80 -0.75%
Syngene International R317.15 -1.05%
Torrent Pharmaceuticals R1,709.65 -0.67%
As on Sep 16, 15:59